AstraZeneca BioPharmaceuticals, Gaithersburg (United States of America)
Member of:
Jieling Chen is a health economist and outcomes researcher with 20 years of experience in health care industry. Expertise includes real-world evidence generation, health service research, economic modeling, and outcomes research. She has extensive experience in diabetes, cardiovascular disease, and vaccine areas.
Outside of work, Jieling enjoys reading non-fiction books and listening to podcasts, especially those on improving healthspan. Easy hikes, Pilates, and eating out with friends are her favorite activities.
A pooled health-economic analysis of DAPA-HF and DELIVER: A French cost-effectiveness analysis of dapagliflozin for the treatment of patients with heart failure